Prednisone and Folotyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisone (prednisone) and Folotyn (pralatrexate). Common drug interactions include cellulitis among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisone and Folotyn. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Folotyn?

Folotyn has active ingredients of pralatrexate. eHealthMe is studying from 522 Folotyn users. Check the latest studies of Folotyn.

On Jul, 08, 2026

12 people who take Prednisone and Folotyn together, and have interactions are studied.

Prednisone and Folotyn drug interactions.

What are the common drug interactions of Prednisone and Folotyn, by gender? *:

female:

Cellulitis (infection under the skin)
Decreased activity
Disease recurrence
Mucosal inflammation (infection of mucous membrane)
Pulmonary embolism (blockage of the main artery of the lung)
Sinusitis fungal (fungal infection of sinus)
Breast cancer
Carcinoid tumour (slow growing tumour)
Cardiac valve disease (heart valve disease)
Cor pulmonale (enlargement of the right ventricle of the heart)

male:

Anaemia (lack of blood)
Cytomegalovirus infection
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bilirubin conjugated increased
Blood albumin decreased
Blood alkaline phosphatase increased
Blood bilirubin increased

What are the common drug interactions of Prednisone and Folotyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Disease recurrence
Mucosal inflammation (infection of mucous membrane)
Sinusitis fungal (fungal infection of sinus)

30-39:

n/a

40-49:

n/a

50-59:

Fatigue (feeling of tiredness)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

60+:

Anaemia (lack of blood)
Cytomegalovirus infection
Cellulitis (infection under the skin)
Decreased activity
Pulmonary embolism (blockage of the main artery of the lung)
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bilirubin conjugated increased
Blood albumin decreased

What are the existing conditions these people have? *

Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 4 people, 33.33%
T-Cell Lymphoma (a blood cell cancer): 2 people, 16.67%
T-Cell Lymphoma Recurrent (reoccurs a blood cell cancer): 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 1 person, 8.33%
Anaplastic Large Cell Lymphoma T- And Null-Cell Types (t-cell or null-cell cancer, a type of blood cancer): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and Folotyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously